Invicta Diagnostic Limited (NSE:INVICTA)

Market Cap	817.18M
Revenue (ttm)	330.42M +382.9%
Net Income	49.06M
EPS	4.90
Shares Out	12.57M
PE Ratio	13.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,400
Open	64.25
Previous Close	65.75
Day's Range	64.20 - 68.00
52-Week Range	58.10 - 105.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 18, 2026

About Invicta Diagnostic

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access mo...

• Industry: Medical Laboratories
• Founded: 2016
• Employees: 113
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INVICTA

Financial Performance

In fiscal year 2026, Invicta Diagnostic's revenue was 330.42 million, an increase of 9.48% compared to the previous year's 301.81 million. Earnings were 49.06 million, an increase of 0.30%.